About US
Contact us
-
UK Pharma Companies to Feel the Pressure of NHS Red ListsThe UK National Health Service's decision to prevent family doctors from prescribing drugs will have a negative impact on the pharmaceutical industry, a health expert has warned. Janet Knowles, par2011/4/15
-
PDA/EMA - Joint Conference - Regulation, Cooperation, InnovationOverview Dear Colleagues, PDA and the European Medicine Agency welcome you to the 2011 PDA-EMA Conference in London. Planning for this year’s conference, the fourth in this series, started in May2011/4/15
-
Patients with breast cancer can benefit from new nanobodiesA new discovery published online in The FASEB Journal (http://www.fasebj.org) promises to help physicians identify patients most likely to benefit from breast cancer drug therapies. If the compound, c2011/4/14
-
Merck and Sun Pharma Announce Joint VentureUS drug manufacturer Merck has formed a joint venture with India-based Sun Pharmaceutical in order to bring innovative formulations to emerging markets. The joint venture plans to developed innova2011/4/14
-
ISP to Sponsor Discussion about Continuous Manufacturing of Pharmaceuticals at ExcipientFest AmericasSpeaker’s Roundtable to Address Transition From Batch Operations to Continuous Operations ISP, a major supplier of ingredients and development services to the pharmaceutical manufacturing industrie2011/4/13
-
Roche Reports Positive Results from Breast Cancer Drug TrialRoche has reported positive topline results from its first randomised trial of trastuzumab emtansine (T-DM1), an antibody-drug conjugate, in HER2-positive metastatic breast cancer. The randomised,2011/4/13
-
China’s first CroscarmelloseSodium（CCNA）manufacturing line is constructed and put into operationRecently Anhui Shanhe(china pharmaceutical excipient manufacturing company)successfully got CroscarmelloseSodium（CCNA） developed and put into production. CCNA is an effective dissolution aid as well a2011/4/11
-
FDA Clears AstraZeneca Medullary Thyroid Cancer DrugAstraZeneca has received approval from the US Food and Drug Administration (FDA) for vandetanib as a treatment for late-stage medullary thyroid cancer in adults who are ineligible for surgery and whos2011/4/11
-
Nanomedicine Could Hold the Key to Treating Drug-Resistant DiseasesIBM Research and the Institute of Bioengineering and Nanotechnology have developed a revolutionary drug-delivery technique that could provide an answer to treating notoriously drug-resistant superbugs2011/4/11
-
AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancerAstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) approved the orphan drug vandetanib for the treatment of medullary thyroid cancer that cannot be removed by sur2011/4/8